Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.00
Bid: 51.50
Ask: 54.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.825%)
Open: 53.00
High: 53.00
Low: 53.00
Prev. Close: 53.00
BVT Live PriceLast checked at -
Baronsmead Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Supplementary Prospectus

19 Jan 2024 14:35

RNS Number : 3453A
Baronsmead Venture Trust PLC
19 January 2024

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS.

Baronsmead Venture Trust plc

LEI: 213800VQ1PQHOJXDDQ88

19 January 2024

Issue of Supplementary Prospectus

Baronsmead Venture Trust plc (the "Company") and Baronsmead Second Venture Trust plc (together, the "Companies") have today published a supplementary prospectus (the "Supplementary Prospectus") in relation to offers for subscription to raise up to £30 million in aggregate with the discretion to utilise over-allotment facilities to raise up to a further £20 million in aggregate (the "Offers" and each an "Offer").

The Supplementary Prospectus refers to the publication of the respective annual reports and audited financial statements for the financial year ended 30 September 2023 by the Companies (the "2023 Report and Accounts"), certain information from which is incorporated by reference into the Supplementary Prospectus. Reference is also made in the Supplementary Prospectus to the change to the first allotment date which was announced on 4 January 2024.

Copies of the Supplementary Prospectus and the 2023 Report and Accounts have been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National Storage Mechanism, which is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Copies of this Supplementary Prospectus, together with the Prospectus (published by the Companies in connection with the Offers dated 24 November 2023) to which the Supplementary Prospectus relates, are available from the following website: http://www.baronsmeadvcts.co.uk and on request by emailing: baronsmeadvcts@greshamhouse.com.

For fundraising enquiries please contact Gresham House on 020 875 9851 or email: wholesaledistribution@greshamhouse.com.

For VCT administration enquiries, please contact:

Baronsmead VCT Investor Relations

Telephone: +44 (0)20 7382 0999

baronsmeadvcts@greshamhouse.com

Notes

This announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Baronsmead Venture Trust plc or Baronsmead Second Venture Trust plc (together the "Companies") in any jurisdiction, including in or into the United States, Australia, Canada, Japan or the Republic of South Africa. Investors should not subscribe for or purchase any ordinary shares referred to in this announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published on 24 November 2023 by Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc in connection with the proposed admission of new ordinary shares to the premium segment of the Official List of the FCA and to trading on London Stock Exchange plc's main market for listed securities (together with the Supplementary Prospectus). Copies of the Prospectus and the Supplementary Prospectus are available for inspection, subject to certain access restrictions, from the Companies' registered office, for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Companies' website (http://www.baronsmeadvcts.co.uk). Approval of the Prospectus and the Supplementary Prospectus by the FCA should not be understood as an endorsement of the securities that are the subject of the Prospectus and the Supplementary Prospectus. Potential investors are recommended to read the Prospectus and the Supplementary Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Companies' securities.

The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This announcement does not constitute, and may not be construed as, an offer to sell, or the solicitation of an offer to acquire or subscribe for, securities of the Companies in any jurisdiction where such offer or solicitation is unlawful or would impose any unfulfilled registration, qualification, publication or approval requirements on either of the Companies or Howard Kennedy Corporate Services LLP. The offer and sale of securities of the Companies has not been and will not be registered under the applicable securities laws of the United States, Australia, Canada, Japan or the Republic of South Africa. Subject to certain exemptions, the securities of the Companies may not be offered to or sold within the United States, Australia, Canada, Japan or the Republic of South Africa or to any national, resident or citizen of the United States, Australia, Canada, Japan or the Republic of South Africa.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities of the Companies have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States or to any national, resident or citizen of the United States. No public offering of securities is being made in the United States. In addition, the Companies have not been and the Companies will not be registered under the US Investment Company Act of 1940, as amended.

The information in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. The material contained in this announcement is given as at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment. In particular, any proposals referred to herein are subject to revision and amendment.

This announcement does not constitute a recommendation concerning the Companies or the Offers. The price and value of securities and any income from them can go down as well as up. Past performance is not a guide to future performance and prospective investors may not receive any return from either Company. Before purchasing any securities of either Company, persons viewing this announcement should ensure that they fully understand and accept the risks set out in the Prospectus and the Supplementary Prospectus. Information in this announcement or any of the documents relating to the Companies or the Offers cannot be relied upon as a guide to future performance. Potential investors should consult a professional adviser as to the suitability of the Offers for them.

Howard Kennedy Corporate Services LLP, which is authorised and regulated by the FCA, is acting only for the Companies in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Howard Kennedy Corporate Services LLP or advice to any other person in relation to the matters contained herein.

Neither Howard Kennedy Corporate Services LLP, the Companies, or any of their respective parents or subsidiary undertakings, or the subsidiary undertakings of any such parent undertakings, or any of such person's respective directors, partners, officers, employees, agents, affiliates or advisers or any other person ("their respective affiliates") accepts (save where required by law) any responsibility or liability whatsoever for/or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
PSPUKOSRSRUAAAR
Date   Source Headline
3rd Sep 20203:30 pmRNSNet Asset Value(s)
6th Aug 20202:45 pmRNSNet Asset Value(s)
3rd Aug 20202:30 pmRNSTotal Voting Rights
30th Jul 20206:10 pmRNSTransaction in Own Shares
22nd Jul 20207:00 amRNSIntention to Fundraise
17th Jul 202011:00 amRNSNet Asset Value(s)
1st Jul 20207:00 amRNSTotal Voting Rights
10th Jun 20201:10 pmRNSTransaction in Own Shares
4th Jun 20205:00 pmRNSNet Asset Value(s)
4th Jun 20207:00 amRNSDividend Declaration
4th Jun 20207:00 amRNSHalf-year Report
12th May 20203:30 pmRNSNet Asset Value(s)
5th May 20205:00 pmRNSNet Asset Value(s)
8th Apr 20203:00 pmRNSNet Asset Value(s)
1st Apr 202012:58 pmRNSTotal Voting Rights
30th Mar 20205:28 pmRNSTransaction in Own Shares
25th Mar 20204:50 pmRNSNet Asset Value(s)
18th Mar 202010:39 amRNSOffer for Subscription - Update
10th Mar 20203:53 pmRNSDirector/PDMR Shareholding
6th Mar 20203:30 pmRNSNet Asset Value(s)
6th Mar 20202:57 pmRNSUpdate on the Offer for Subscription
2nd Mar 20204:05 pmRNSTotal Voting Rights
27th Feb 20203:11 pmRNSIssue of new shares
26th Feb 20203:44 pmRNSResult of AGM
7th Feb 202010:00 amRNSNet Asset Value(s)
3rd Feb 20207:00 amRNSTotal Voting Rights
27th Jan 20205:37 pmRNSDirector/PDMR Shareholding
24th Jan 20208:15 amRNSTransaction in Own Shares
23rd Jan 202011:45 amRNSIssue of New Shares
17th Jan 202012:01 pmRNSDirector Declaration
9th Jan 20203:00 pmRNSReplacement Net Asset Value(s)
9th Jan 202010:10 amRNSNet Asset Value(s)
2nd Jan 20209:00 amRNSTotal Voting Rights
30th Dec 20193:56 pmRNSTransaction in Own Shares
13th Dec 201912:41 pmRNSOffer Update - Change To Allotment Date
5th Dec 20195:00 pmRNSNet Asset Value(s)
2nd Dec 20194:42 pmRNSTotal Voting Rights
28th Nov 20194:35 pmRNSTransaction in Own Shares
25th Nov 20194:58 pmRNSDirector/PDMR Shareholding
25th Nov 20193:35 pmRNSPublication of Suppl.Prospcts
25th Nov 20197:00 amRNSAnnual Financial Report for the y/e 30/09/2019
20th Nov 201912:31 pmRNSIssue of New Shares
6th Nov 20195:40 pmRNSPDMR Shareholding
6th Nov 20195:15 pmRNSNet Asset Value(s)
1st Nov 201911:41 amRNSTotal Voting Rights
11th Oct 20194:00 pmRNSNet Asset Value(s)
10th Oct 20195:37 pmRNSTransaction in Own Shares
4th Oct 20199:00 amRNSPublication of a Prospectus
1st Oct 20195:53 pmRNSTotal Voting Rights
30th Sep 20195:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.